Cargando…
Median Effective Dose of Intranasal Dexmedetomidine for Transthoracic Echocardiography in Children with Kawasaki Disease Who Have a History of Repeated Sedation
BACKGROUND: The aim of this study was to investigate the median effective dose (ED50) of intranasal dexmedetomidine for echocardiography in children with Kawasaki disease who had a history of repeated sedation. MATERIAL/METHODS: There were 73 pediatric Kawasaki disease patients aged 1 to 36 months e...
Autores principales: | Gu, Hong-Bin, Song, Yun-An, Bai, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340313/ https://www.ncbi.nlm.nih.gov/pubmed/30636258 http://dx.doi.org/10.12659/MSM.912517 |
Ejemplares similares
-
ED50 of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children with or without a History of Cardiac Surgery for Cyanotic Congenital Heart Disease
por: Gu, HongBin, et al.
Publicado: (2020) -
Comparative Study of Intranasal Dexmedetomidine v/s Midazolam for Sedation of Pediatric Patients During Transthoracic Echocardiography
por: Panda, Suvendu, et al.
Publicado: (2021) -
Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
por: Cossovel, Francesca, et al.
Publicado: (2022) -
An Evaluation of Intranasal Sufentanil and Dexmedetomidine for Pediatric Dental Sedation
por: Hitt, James M., et al.
Publicado: (2014) -
Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children
por: Chen, Hang, et al.
Publicado: (2020)